# AX Pharmaceutical Corporation – FDA Inspection, Sep 1, 2017

Source: https://www.keypedia.com/records/fda_inspections/ax-pharmaceutical-corporation/9bed0c81-dd35-4ab2-a259-a81c2471bf81
Source feed: FDA_Inspections

> FDA inspection 1027810 of AX Pharmaceutical Corporation, September 01, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1027810
- Company Name: AX Pharmaceutical Corporation
- Inspection Date: 2017-09-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1236258 - 2024-03-05
- [FDA Inspection 1169095 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/ax-pharmaceutical-corporation/ed40eb38-a050-47af-b183-99b67ff693e9)
- FDA Inspection 973398 - 2016-05-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783)

Company: https://www.keypedia.com/companies/ax-pharmaceutical-corporation/edd09f02-a326-4fd4-9b78-0db6bd74b76d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
